To screen diagnostic and prognostic miRNAs in ALK+ NSCLC patients, Li et al. conducted a microarray analysis of plasma samples from a small subset of NSCLC patients (3 ALK+ and 3 ALK−) and healthy subjects [146]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.